C17orf85 Inhibitors
C17orf85 inhibitors consits of Staurosporine and LY294002 inhibit kinases within the cell, which can have downstream effects on multiple signaling pathways that may intersect with C17orf85's function. Rapamycin specifically inhibits the mTOR pathway, a central regulator of cell growth and metabolism, which could influence the activity or expression of C17orf85.
Trichostatin A and 5-Azacytidine act epigenetically to modulate gene expression. By inhibiting histone deacetylases and DNA methyltransferases, respectively, they can alter the chromatin structure and thereby affect the expression of a broad range of genes, including possibly C17orf85. PD98059, SB203580, and SP600125 target different MAP kinases, which are important in regulating cell proliferation, apoptosis, and stress responses. The inhibition of these kinases can lead to changes in cellular processes that C17orf85 may be a part of. Calcium signaling, which is crucial for many cellular functions including cell cycle control and apoptosis, can be affected by the calmodulin inhibitor W7 and the calcium chelator BAPTA-AM.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent protein kinase inhibitor which can modulate signal transduction pathways that C17orf85 may be involved in. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor which can alter the PI3K/Akt pathway, possibly affecting processes where C17orf85 plays a role. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor which can impact cell growth and proliferation, processes that can involve C17orf85. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor which can change gene expression patterns, potentially affecting C17orf85 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor which can lead to changes in gene expression, possibly influencing C17orf85 levels. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor which can affect the MAPK/ERK pathway and potentially the function of C17orf85. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor which can modulate inflammation and stress response pathways involving C17orf85. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK which can alter apoptosis and cell differentiation pathways where C17orf85 may be implicated. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
A calmodulin inhibitor which can affect calcium signaling pathways that C17orf85 may be part of. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
A calcium chelator which can disrupt intracellular calcium levels, potentially affecting C17orf85-associated processes. | ||||||